Advanced Therapies Medical Products (ATMPs) are considered the “drugs of the future”. These are based on gene, cell and tissue products. Sweden has the ambitious goal of becoming a leader in ATMPs and for this it is important to manage research efforts in an efficient way, facilitating the clinical translation of such innovative therapies. Within this thematic, Pharma Industry Publishing AB published a report on the development of ATMPs in Sweden, where Asgard Therapeutics was featured.